Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:55 UTC |
---|
HMDB ID | HMDB0015270 |
---|
Secondary Accession Numbers | - HMDB0030451
- HMDB15270
- HMDB30451
|
---|
Metabolite Identification |
---|
Common Name | Cephapirin |
---|
Description | Cephapirin is an injectable, first-generation cephalosporin antibiotic that has a wide spectrum of activity against gram-positive and gram-negative organisms. The bactericidal activity of cephapirin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cephapirin is more resistant to beta-lactamases than the penicillins, and therefore is effective against staphylococci, with the exception of methicillin-resistant staphylococci. Cephapirin is FDA approved for use in food-producing animals, especially dairy cattle. Cephapirin is used for the treatment of mastitis in cows. Production for use in humans has been discontinued in the United States. It is marketed under the trade name Cefadyl. |
---|
Structure | [H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CSC1=CC=NC=C1)C(O)=O InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(6R,7R)-3-(Acetoxymethyl)-8-oxo-7-{[(pyridin-4-ylsulfanyl)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | ChEBI | Cefapirin | ChEBI | Cefapirina | ChEBI | Cefapirine | ChEBI | Cefapirinum | ChEBI | Cefaprin | ChEBI | Cephapirine | ChEBI | CEPR | ChEBI | Metricure | Kegg | (6R,7R)-3-(Acetoxymethyl)-8-oxo-7-{[(pyridin-4-ylsulfanyl)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | Generator | (6R,7R)-3-(Acetoxymethyl)-8-oxo-7-{[(pyridin-4-ylsulphanyl)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | Generator | (6R,7R)-3-(Acetoxymethyl)-8-oxo-7-{[(pyridin-4-ylsulphanyl)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Generator | Cefadyl | HMDB | Monosodium salt, cephapirin | HMDB | Salt, cephapirin monosodium | HMDB | BL p 1322 | HMDB | Bristol-myers brand OF cephapirin sodium | HMDB | Cephapirin, sodium | HMDB | Apothecon brand OF cephapirin sodium | HMDB | Cephapirin sodium | HMDB | Céfaloject | HMDB | Sodium cephapirin | HMDB | BL-p 1322 | HMDB | Brisfirina | HMDB | Bristol-myers squibb brand OF cephapirin sodium | HMDB | Cephapirin monosodium salt | HMDB | Cephapirin | KEGG |
|
---|
Chemical Formula | C17H17N3O6S2 |
---|
Average Molecular Weight | 423.463 |
---|
Monoisotopic Molecular Weight | 423.055876671 |
---|
IUPAC Name | (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(pyridin-4-ylsulfanyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
---|
Traditional Name | CEPR |
---|
CAS Registry Number | 21593-23-7 |
---|
SMILES | [H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CSC1=CC=NC=C1)C(O)=O |
---|
InChI Identifier | InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1 |
---|
InChI Key | UQLLWWBDSUHNEB-CZUORRHYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. N-acyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | N-acyl-alpha amino acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - N-acyl-alpha amino acid or derivatives
- Cephem
- Aryl thioether
- Alkylarylthioether
- Meta-thiazine
- Dicarboxylic acid or derivatives
- Pyridine
- Heteroaromatic compound
- Beta-lactam
- Tertiary carboxylic acid amide
- Carboxamide group
- Carboxylic acid ester
- Lactam
- Azetidine
- Azacycle
- Organoheterocyclic compound
- Carboximidic acid
- Carboximidic acid derivative
- Dialkylthioether
- Carboxylic acid
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Sulfenyl compound
- Thioether
- Hemithioaminal
- Hydrocarbon derivative
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Organosulfur compound
- Organopnictogen compound
- Carbonyl group
- Organic oxide
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.15 g/L | Not Available | LogP | -0.1 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Cephapirin,1TMS,isomer #1 | CC(=O)OCC1=C(C(=O)O[Si](C)(C)C)N2C(=O)[C@@H](NC(=O)CSC3=CC=NC=C3)[C@H]2SC1 | 3370.2 | Semi standard non polar | 33892256 | Cephapirin,1TMS,isomer #2 | CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](N(C(=O)CSC3=CC=NC=C3)[Si](C)(C)C)[C@H]2SC1 | 3295.9 | Semi standard non polar | 33892256 | Cephapirin,2TMS,isomer #1 | CC(=O)OCC1=C(C(=O)O[Si](C)(C)C)N2C(=O)[C@@H](N(C(=O)CSC3=CC=NC=C3)[Si](C)(C)C)[C@H]2SC1 | 3197.4 | Semi standard non polar | 33892256 | Cephapirin,2TMS,isomer #1 | CC(=O)OCC1=C(C(=O)O[Si](C)(C)C)N2C(=O)[C@@H](N(C(=O)CSC3=CC=NC=C3)[Si](C)(C)C)[C@H]2SC1 | 2999.1 | Standard non polar | 33892256 | Cephapirin,2TMS,isomer #1 | CC(=O)OCC1=C(C(=O)O[Si](C)(C)C)N2C(=O)[C@@H](N(C(=O)CSC3=CC=NC=C3)[Si](C)(C)C)[C@H]2SC1 | 4747.4 | Standard polar | 33892256 | Cephapirin,1TBDMS,isomer #1 | CC(=O)OCC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)[C@@H](NC(=O)CSC3=CC=NC=C3)[C@H]2SC1 | 3542.4 | Semi standard non polar | 33892256 | Cephapirin,1TBDMS,isomer #2 | CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](N(C(=O)CSC3=CC=NC=C3)[Si](C)(C)C(C)(C)C)[C@H]2SC1 | 3487.8 | Semi standard non polar | 33892256 | Cephapirin,2TBDMS,isomer #1 | CC(=O)OCC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)[C@@H](N(C(=O)CSC3=CC=NC=C3)[Si](C)(C)C(C)(C)C)[C@H]2SC1 | 3590.8 | Semi standard non polar | 33892256 | Cephapirin,2TBDMS,isomer #1 | CC(=O)OCC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)[C@@H](N(C(=O)CSC3=CC=NC=C3)[Si](C)(C)C(C)(C)C)[C@H]2SC1 | 3377.3 | Standard non polar | 33892256 | Cephapirin,2TBDMS,isomer #1 | CC(=O)OCC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)[C@@H](N(C(=O)CSC3=CC=NC=C3)[Si](C)(C)C(C)(C)C)[C@H]2SC1 | 4774.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Cephapirin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9373100000-e3d19d32bd32937d2df3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cephapirin GC-MS (1 TMS) - 70eV, Positive | splash10-00dl-9221200000-5b079bfce3f72569ddd8 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cephapirin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 10V, Positive-QTOF | splash10-0ck9-1193200000-dbd8b4f9cdd95af96beb | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 20V, Positive-QTOF | splash10-0aor-3493000000-9715d40cfca13766b646 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 40V, Positive-QTOF | splash10-0903-9740000000-3730a9b0ee7ce8523e45 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 10V, Negative-QTOF | splash10-0bt9-2693100000-30db005d7cf1f9280b9a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 20V, Negative-QTOF | splash10-08fr-5982000000-04fa910b005391b04891 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 40V, Negative-QTOF | splash10-03dl-9470000000-f3f678bd4350e63bc6bd | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 10V, Negative-QTOF | splash10-00di-0018900000-9afce8e794a582cdcf94 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 20V, Negative-QTOF | splash10-03di-4932100000-cfcc654bebe5ca1a549a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 40V, Negative-QTOF | splash10-03dl-9610000000-a89d7ebde3d9ad8d7ac2 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 10V, Positive-QTOF | splash10-0229-0008900000-d203511cd0ef491771f2 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 20V, Positive-QTOF | splash10-03di-1954100000-54810442e303dd9f9e41 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cephapirin 40V, Positive-QTOF | splash10-03l0-3920000000-099e86960b6137b68872 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum |
|
---|